
Articles
-
Dec 19, 2024 |
epigram.org.uk | Emily MacLean |Emily Maclean
By Emily MacLean, First Year EnglishOn a typical rainy Sunday evening in Bristol, the sold-out crowd at the O2 Academy found refuge in the infectious energy of The Snuts’ unforgettable performance. The eclectic crowd, spanning a wide range of ages, was united by their enthusiasm for The Snuts, with many fans proudly wearing the band’s merchandise as a symbol of their devotion. One of the evening’s greatest rewards was the chance to experience the opening performance by Siobhán Winifred.
-
May 30, 2024 |
mg.co.za | Emily MacLean |Emily Maclean
Global development chief of Amref Health Africa Githinji Gitahi abruptly left a World Health Assembly stage when he found himself on an all-male panel at last year’s summit. Murmurs swept the hushed conference room in Geneva, Switzerland, where member states had gathered to hear the chief executive of Amref, a health development NGO, discuss the way forward on climate resilience.
-
May 8, 2024 |
err.ersjournals.com | Emily MacLean |Emily Maclean |Greg Fox
IntroductionIn recent years, the concept of the tuberculosis (TB) disease spectrum has emerged, recognising that TB exists along a continuum ranging from latent infection through incipient and subclinical disease to active TB disease [1, 2]. Depending on immune status, genetic factors and the presence of comorbidities, individuals can progress or regress along this spectrum [3, 4].
-
Apr 4, 2024 |
thelancet.com | Emily MacLean |Emily Maclean |H Manisha Yapa
Tuberculosis is a leading cause of morbidity and mortality among people living with HIV. 1WHOGlobal tuberculosis report 2023. Diagnosing tuberculosis in people living with HIV is often challenging, but even tests with moderate accuracy can be helpful when deployed in an appropriate diagnostic algorithm.
-
Apr 14, 2023 |
thelancet.com | Emily MacLean |Emily Maclean |Mikashmi Kohli |Patricia Espinoza-Lopez |Tatiana Caceres
SummaryBackgroundIntegrated molecular testing could be an opportunity to detect and provide care for both tuberculosis and COVID-19. Many high tuberculosis burden countries, such as Peru, have existing GeneXpert systems for tuberculosis testing with GeneXpert Xpert MTB/RIF Ultra (Xpert Ultra), and a GeneXpert SARS-CoV-2 assay, GeneXpert Xpert Xpress SARS-CoV-2 (Xpert Xpress), is also available.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →